☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Avaxim stock shortage

The manufacturer of Avaxim®, a hepatitis A vaccine, has written to healthcare professionals advising of a global shortage of this product.

The supply issues are as a result of a manufacturing problem and the manufacturer is currently unable to meet any orders.

Action: Clinicians should be aware of this shortage and seek an alternative supplier if affected.

Share 'Avaxim stock shortage' by emailShare 'Avaxim stock shortage' on FacebookShare 'Avaxim stock shortage' on TwitterShare 'Avaxim stock shortage' on LinkedInShare 'Avaxim stock shortage' on reddit


No Comments to “Avaxim stock shortage”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.